N316B Midterm 1 2025/2026 Exam
Questions and Corresponding Answers
with Surety of 100% Pass Mark
Which statements would the nurse include when teaching a client who is
considering medroxyprogesterone injection as a form of hormonal birth
control? Select all that apply. One, some, or all responses may be correct.
-It lasts for 3 months.
-It can cause nausea and vomiting.
-It contains both progestin and estrogen.
-It decreases the risk of age-related loss of bone density.
-Side effects include drowsiness or insomnia and depression.
-The most severe undesirable effects are liver dysfunction and
thromboembolic disorders. - 🧠 ANSWER ✔✔*It lasts for 3 months.
*It can cause nausea and vomiting.
*Side effects include drowsiness or insomnia and depression.
COPYRIGHT©BLAIRALISTERNEWTON 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
1
PRIVACY STATEMENT. ALL RIGHTS RESERVED
,*The most severe undesirable effects are liver dysfunction and
thromboembolic disorders.
Rationale
Medroxyprogesterone does last for 3 months. It can cause nausea and
vomiting, as well as lethargy or insomnia and depression, although the
most undesirable severe effects are liver dysfunction and thromboembolic
disorders, including thrombophlebitis, cerebrovascular disorder, pulmonary
embolism, and retinal thrombosis. Medroxyprogesterone does not contain
both progestin and estrogen; it is progestin-only. Medroxyprogesterone
does not decrease the risk of age-related loss of bone density; in fact, it
has a black-box warning because it can cause bone mineral density loss
that puts women at higher risk for osteoporosis and bone fractures later in
life.
A client with myasthenia gravis has been receiving neostigmine and asks
about its action. Which information would the nurse consider when
formulating a response?
- Stimulates the cerebral cortex
COPYRIGHT©BLAIRALISTERNEWTON 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
2
PRIVACY STATEMENT. ALL RIGHTS RESERVED
,- Blocks the action of cholinesterase
- Replaces deficient neurotransmitters
- Accelerates transmission along neural sheaths - 🧠 ANSWER ✔✔Blocks
the action of cholinesterase
Rationale:
Neostigmine, an anticholinesterase, inhibits the breakdown of
acetylcholine, thus prolonging neurotransmission. Neostigmine's action is
at the myoneural junction, not the cerebral cortex. Neostigmine prevents
neurotransmitter breakdown, but it is not a neurotransmitter. Neostigmine's
action is at the myoneural junction, not the sheath.
773) The health care provider prescribes neostigmine for a client with
myasthenia gravis. Which client statement indicates understanding
regarding medication management plans?
- 'I must keep the medication in a container in the refrigerator.'
- I should take the medication at the exact time that is listed on the
prescription.'
COPYRIGHT©BLAIRALISTERNEWTON 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
3
PRIVACY STATEMENT. ALL RIGHTS RESERVED
, -'I will plan to take the medication between meals.'
-'I expect that the onset of the medication's action will occur several hours
after I take it.' - 🧠 ANSWER ✔✔- I should take the medication at the exact
time that is listed on the prescription.'
Rationale:
Neostigmine should be taken as prescribed, usually before meals, to limit
dysphagia and possible aspiration. Keeping neostigmine refrigerated is not
necessary; it may be kept at room temperature. Neostigmine should be
taken with milk to prevent gastrointestinal irritation; usually it is taken about
30 minutes before meals. The onset of the action of neostigmine occurs 45
to 75 minutes after administration; the duration of its action is 2.5 to 4
hours.
Pyridostigmine bromide is prescribed for a client with myasthenia gravis.
The nurse evaluates that the medication regimen is understood when the
client makes which statement?
-'I will take the medication on an empty stomach.'
COPYRIGHT©BLAIRALISTERNEWTON 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
4
PRIVACY STATEMENT. ALL RIGHTS RESERVED
Questions and Corresponding Answers
with Surety of 100% Pass Mark
Which statements would the nurse include when teaching a client who is
considering medroxyprogesterone injection as a form of hormonal birth
control? Select all that apply. One, some, or all responses may be correct.
-It lasts for 3 months.
-It can cause nausea and vomiting.
-It contains both progestin and estrogen.
-It decreases the risk of age-related loss of bone density.
-Side effects include drowsiness or insomnia and depression.
-The most severe undesirable effects are liver dysfunction and
thromboembolic disorders. - 🧠 ANSWER ✔✔*It lasts for 3 months.
*It can cause nausea and vomiting.
*Side effects include drowsiness or insomnia and depression.
COPYRIGHT©BLAIRALISTERNEWTON 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
1
PRIVACY STATEMENT. ALL RIGHTS RESERVED
,*The most severe undesirable effects are liver dysfunction and
thromboembolic disorders.
Rationale
Medroxyprogesterone does last for 3 months. It can cause nausea and
vomiting, as well as lethargy or insomnia and depression, although the
most undesirable severe effects are liver dysfunction and thromboembolic
disorders, including thrombophlebitis, cerebrovascular disorder, pulmonary
embolism, and retinal thrombosis. Medroxyprogesterone does not contain
both progestin and estrogen; it is progestin-only. Medroxyprogesterone
does not decrease the risk of age-related loss of bone density; in fact, it
has a black-box warning because it can cause bone mineral density loss
that puts women at higher risk for osteoporosis and bone fractures later in
life.
A client with myasthenia gravis has been receiving neostigmine and asks
about its action. Which information would the nurse consider when
formulating a response?
- Stimulates the cerebral cortex
COPYRIGHT©BLAIRALISTERNEWTON 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
2
PRIVACY STATEMENT. ALL RIGHTS RESERVED
,- Blocks the action of cholinesterase
- Replaces deficient neurotransmitters
- Accelerates transmission along neural sheaths - 🧠 ANSWER ✔✔Blocks
the action of cholinesterase
Rationale:
Neostigmine, an anticholinesterase, inhibits the breakdown of
acetylcholine, thus prolonging neurotransmission. Neostigmine's action is
at the myoneural junction, not the cerebral cortex. Neostigmine prevents
neurotransmitter breakdown, but it is not a neurotransmitter. Neostigmine's
action is at the myoneural junction, not the sheath.
773) The health care provider prescribes neostigmine for a client with
myasthenia gravis. Which client statement indicates understanding
regarding medication management plans?
- 'I must keep the medication in a container in the refrigerator.'
- I should take the medication at the exact time that is listed on the
prescription.'
COPYRIGHT©BLAIRALISTERNEWTON 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
3
PRIVACY STATEMENT. ALL RIGHTS RESERVED
, -'I will plan to take the medication between meals.'
-'I expect that the onset of the medication's action will occur several hours
after I take it.' - 🧠 ANSWER ✔✔- I should take the medication at the exact
time that is listed on the prescription.'
Rationale:
Neostigmine should be taken as prescribed, usually before meals, to limit
dysphagia and possible aspiration. Keeping neostigmine refrigerated is not
necessary; it may be kept at room temperature. Neostigmine should be
taken with milk to prevent gastrointestinal irritation; usually it is taken about
30 minutes before meals. The onset of the action of neostigmine occurs 45
to 75 minutes after administration; the duration of its action is 2.5 to 4
hours.
Pyridostigmine bromide is prescribed for a client with myasthenia gravis.
The nurse evaluates that the medication regimen is understood when the
client makes which statement?
-'I will take the medication on an empty stomach.'
COPYRIGHT©BLAIRALISTERNEWTON 2025/2026. YEAR PUBLISHED 2025. COMPANY REGISTRATION NUMBER: 619652435. TERMS OF USE.
4
PRIVACY STATEMENT. ALL RIGHTS RESERVED
